Kim CO

References (2)

Title : Pharmacokinetics and safety of evogliptin in hepatically impaired patients - Hong_2021_Br.J.Clin.Pharmacol_87_2757
Author(s) : Hong T , Jin BH , Kim CO , Yoo BW , Kim D , Lee JI , Kim BK , Ahn SH , Kim DY , Park JY , Park MS
Ref : British Journal of Clinical Pharmacology , 87 :2757 , 2021
Abstract : Hong_2021_Br.J.Clin.Pharmacol_87_2757
ESTHER : Hong_2021_Br.J.Clin.Pharmacol_87_2757
PubMedSearch : Hong_2021_Br.J.Clin.Pharmacol_87_2757
PubMedID: 33245796

Title : Effects of clarithromycin on the pharmacokinetics of evogliptin in healthy volunteers - Oh_2017_J.Clin.Pharm.Ther_42_689
Author(s) : Oh ES , Choi C , Kim CO , Kim KH , Kim YN , Kim SJ , Park MS
Ref : J Clin Pharm Ther , 42 :689 , 2017
Abstract : Oh_2017_J.Clin.Pharm.Ther_42_689
ESTHER : Oh_2017_J.Clin.Pharm.Ther_42_689
PubMedSearch : Oh_2017_J.Clin.Pharm.Ther_42_689
PubMedID: 28806472